Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity [NA]

View source ↗

Summary

This clinical trial investigates skin elasticity in Wilson disease patients treated with D-penicillamine to characterize treatment-related skin damage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-Penicillamine (D-penicillamine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Wilson Disease, D-Penicillamine | NA | Status: RECRUITING